HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiuping Ji Selected Research

NSC 724998

12/2018NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.
7/2016Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiuping Ji Research Topics

Disease

36Neoplasms (Cancer)
01/2022 - 06/2008
4Triple Negative Breast Neoplasms
01/2022 - 03/2012
4Thrombocytopenia (Thrombopenia)
01/2021 - 04/2012
4Lymphoma (Lymphomas)
12/2018 - 09/2011
3Ewing Sarcoma (Sarcoma, Ewing)
01/2021 - 12/2017
3Circulating Neoplastic Cells
07/2016 - 09/2011
3Ovarian Neoplasms (Ovarian Cancer)
04/2015 - 03/2012
2Neutropenia
01/2021 - 04/2012
2Diarrhea
12/2018 - 07/2016
2Mucositis
11/2017 - 02/2017
2Hematologic Neoplasms (Hematological Malignancy)
11/2017 - 01/2017
2Fanconi Anemia (Fanconi's Anemia)
07/2016 - 11/2012
1Anorexia
01/2021
1Colitis
01/2021
1Endometrial Neoplasms (Endometrial Cancer)
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018
1Melanoma (Melanoma, Malignant)
12/2017
1Sarcoma (Soft Tissue Sarcoma)
12/2017
1Hyponatremia
10/2017
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2017
1Leukemia
02/2017
1Fatigue
07/2016
1Disease Progression
01/2016
1Inflammation (Inflammations)
06/2015
1Hemorrhage
06/2015
1Hemorrhagic Cystitis
06/2015
1Fallopian Tube Neoplasms
04/2015
1Glioblastoma (Glioblastoma Multiforme)
06/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2012

Drug/Important Bio-Agent (IBA)

18Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 06/2009
14veliparibIBA
01/2022 - 06/2009
8Pharmaceutical PreparationsIBA
12/2018 - 06/2008
8Topotecan (Hycamtin)FDA LinkGeneric
01/2018 - 11/2010
7Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022 - 06/2009
6Poly Adenosine Diphosphate RiboseIBA
01/2021 - 06/2009
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 03/2012
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2012
5olaparibIBA
10/2017 - 04/2012
4Carboplatin (JM8)FDA LinkGeneric
11/2017 - 06/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2011
3Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 09/2014
3Histones (Histone)IBA
02/2017 - 10/2015
3Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2014 - 09/2011
2PlatinumIBA
01/2022 - 01/2018
2Alkylating AgentsIBA
01/2022 - 03/2012
2Cytotoxins (Cytolysins)IBA
01/2021 - 01/2017
2adavosertibIBA
01/2021 - 10/2015
2Nicotinamide PhosphoribosyltransferaseIBA
09/2020 - 12/2017
2Topoisomerase I InhibitorsIBA
12/2018 - 09/2011
2CamptothecinIBA
12/2018 - 09/2014
2NSC 724998IBA
12/2018 - 07/2016
2Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 06/2015
1Topoisomerase InhibitorsIBA
01/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1niraparibIBA
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1NAD (NADH)IBA
09/2020
1OT-82IBA
09/2020
1indimitecanIBA
12/2018
1Proteins (Proteins, Gene)FDA Link
12/2018
1Oxygen (Dioxygen)IBA
12/2017
1NADPH Oxidase 5IBA
12/2017
1Bromodeoxyuridine (BrdU)IBA
12/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2017
1Coloring Agents (Dyes)IBA
07/2016
1Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2016
1Nonsense Codon (Nonsense Mutation)IBA
07/2016
1A-Form DNA (A-DNA)IBA
07/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Phosphotransferases (Kinase)IBA
10/2015
1batracylinIBA
06/2015
1IfosfamideFDA LinkGeneric
06/2015
1Mesna (Coenzyme M)FDA LinkGeneric
06/2015
1DNA TopoisomerasesIBA
06/2015
1rucaparibIBA
02/2014
1talazoparibIBA
02/2014
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2013
1Cisplatin (Platino)FDA LinkGeneric
04/2012
1GemcitabineFDA Link
04/2012
1EnzymesIBA
01/2012

Therapy/Procedure

6Therapeutics
12/2018 - 01/2012
2Oral Administration
06/2015 - 03/2012
1Aftercare (After-Treatment)
12/2018
1Drug Therapy (Chemotherapy)
01/2016
1Secondary Prevention
01/2016